Anwar R, Gallivan L, Trinh C, Hill F, Markham A
Molecular Medicine Unit, University of Leeds, Clinical Sciences Building, St James's University Hospital, Leeds, UK.
Eur J Haematol. 2001 Feb;66(2):133-6. doi: 10.1034/j.1600-0609.2001.00370.x.
We report a new homozygous CTG-->CCG (Leu-->Pro) mutation at codon 354 in the factor XIIIA gene of a patient suffering from FXIII deficiency. Leu354 lies in a pocket within the core domain of the FXIIIA molecule, with its side chain pointing into the structure of the barrel 1 domain. Replacement of leucine with a proline residue gives rise to steric hindrance between the proline ring and the surrounding residues, and rearrangement of these residues would be necessary for proline to be accommodated at this position. Using PCR-RFLP, we have demonstrated the absence of this mutation from 220 normal alleles. Together, these data suggest that Leu354Pro is likely to be the disease-causing mutation in this factor XIII deficient family.
我们报告了1例患有因子XIII缺乏症患者的因子XIIIA基因第354密码子处发生了新的纯合CTG→CCG(Leu→Pro)突变。Leu354位于因子XIIIA分子核心结构域内的一个凹槽中,其侧链指向桶状结构域1的结构。用脯氨酸残基取代亮氨酸会导致脯氨酸环与周围残基之间产生空间位阻,并且这些残基需要重新排列才能使脯氨酸容纳在该位置。通过聚合酶链反应-限制性片段长度多态性(PCR-RFLP)分析,我们已证实在220个正常等位基因中不存在该突变。这些数据共同表明,Leu354Pro很可能是这个因子XIII缺乏症家族中的致病突变。